Doç. Dr. Hüseyin Akyol

Expérience

• 2024-HalenMedicana Zincirlikuyu Hastanesimedicana.com.tr
• 2019-2024Altınbaş Üniversitesi Tıp Fakültesi (Dekan Yardımcısı)medicana.com.tr
• 2007-2024Medical Park Bahçelievler Hastanesi, Dr. Öğretim görevlisimedicana.com.tr
• 2005-2007Kırşehir Devlet Hastanesi, Uzman Dr.medicana.com.tr
• 2000-2005Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi, Asistan Dr.medicana.com.tr

Formation

• 1998Uludağ Üniversitesi Tıp Fakültesimedicana.com.tr
• 2005Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesimedicana.com.tr

• SpécialitéChirurgie généralemedicana.com.trD’après la source
• Nom du service dans la sourceObezite ve Metabolik Cerrahimedicana.com.trD’après la source
• ÉtablissementMedicana Zincirlikuyumedicana.com.trD’après la source
• Publications29 publicationspage de profil sur medicana.com.trD’après la source
• Dernière synchronisation7 novembre 2026 03:22https://www.medicana.com.tr/hekim-detay/21831/huseyin-akyolmedicana.com.tr

1. 1.Akyol Hüseyı̇n, Erok Berrı̇n (2021). Factors Affecting the Selection of the Bariatric Surgeon-A Survey Study. International Journal of Clinical Case Reports and Reviews, 9(2), 1-5. Doi: 10.31579/2690-4861/172

   Source : page de profil sur medicana.com.tr

2. 2.Akyol Hüseyı̇n, Erok Berrı̇n (2021). Quality of Information Available on YouTube Videos Pertaining to Bariatric Surgery. International Journal of Clinical Case Reports and Reviews, 9(2), 1- 6. Doi: 10.31579/2690-4861/173

   Source : page de profil sur medicana.com.tr

3. 3.Aydın MA, Akyol H (2020). Quality of Information Available on YouTube Videos Pertaining to Thyroid Cancer. Journal of Cancer Education, 35(3), 599-605. Doi: 10.1007/s13187- 019-01502-9

   Source : page de profil sur medicana.com.tr

4. 4.Yanmaz MT, İzmı̇r GŞ, Satılmış B, Akyol H, Aydın MA (2014). Thirty-minutes infusion rate is safe enough for bevacizumab; no need for initial prolong infusion. Medical Oncology, 31(11), 1-5. Doi: 10.1007/s12032-014-0276-1

   Source : page de profil sur medicana.com.tr

5. 5.Küçük HF, Gülmez S, Kaptanoğlu L, Akyol H, Kurt N, Yavuzer D. (2009) ‘Acute Abdomen Due to Rupture of Hemangiopericytoma of the Greater Omentum: Case Report’’, Ulus Travma Acil Cerrahi Derg, 15, 611-613.

   Source : page de profil sur medicana.com.tr

6. 6.KaptanoğLu L, Küçük HF, Çolak E, Kurt N, Bı̇ngül SM, Akyol H, Torlak OA, Yazıcı F (2008). The effect of taurolidine on experimental thrombus formation. European Journal of Pharmacology, 578(2), 238-241. Doi: 10.1016/j.ejphar.2007.08.035

   Source : page de profil sur medicana.com.tr

7. 7.Küçük HF, KaptanoğLu L, Kurt N, Uzun H, Eser M, Bı̇ngül S, Torlak OA, Akyol H (2007). The Role of Simvastatin on Postoperative Peritoneal Adhesion Formation in an Animal Model. European Surgical Research, 39(2), 98-102. Doi: 10.1159/000099156

   Source : page de profil sur medicana.com.tr

8. 8.Küçük HF, Bı̇ngül SM, Kurt N, KaptanoğLu L, Akyol H, Torlak OA, Çolak E (2006). Effect of a Selective Cyclooxygenase-2 Inhibitor on Renal Scarring. European Surgical Research, 38(5), 451-457. Doi: 10.1159/000095088

   Source : page de profil sur medicana.com.tr

9. 9.Küçük HF, KaptanoğLu L, Özalp F, Kurt N, Bingül SM, Torlak OA, Çolak E, Akyol H, Ege GA (2006). Role of Glyceryl Trinitrate, a Nitric Oxide Donor, in the Renal Ischemia-Reperfusion Injury of Rats. European Surgical Research, 38(5), 431-437. Doi: 10.1159/000095085

   Source : page de profil sur medicana.com.tr

10. 10.Küçük HF, Akyol H, KaptanoğLu L, Kurt N, Özdemı̇r BN, Bı̇ngül S, Torlak OA, Çolak E (2006). Effect of Proton Pump Inhibitors on Hepatic Regeneration. European Surgical Research, 38(3), 322-328. Doi: 10.1159/000094020

    Source : page de profil sur medicana.com.tr